Clinical Plenary #2
Nov
2026
Description
Alcohol is a major contributor to liver disease, yet diagnostic plans and treatment approaches are not standard around the globe. This SOA lecture is aimed to explore a multidisciplinary appraoch to evaluation and treatment.
Presentations
11:30 AM
- 11:45 AM
Convention Center - General Session, Hall A
Alcohol-Related Plasma Proteomic Signature and Risk of Cancer and Mortality: A Prospective Study in the UK Biobank
Loggang Zhao, PhD | Abstract Presenter
11:45 AM
- 12:00 PM
Convention Center - General Session, Hall A
Twelve-Month Biochemical Response to UDCA Predicts Five-Year Decompensation and Mortality in Primary Biliary Cholangitis: A Propensity-Matched Landmark Cohort Study
EzzElDien A. Ibrahim | Abstract Presenter
12:00 PM
- 12:15 PM
Convention Center - General Session, Hall A
Dyserythropoiesis underlies severe refractory anaemia in decompensated cirrhosis through erythropoietin resistance, erythroid differentiation arrest, and impaired cellular cobalamin uptake
Chhagan Bihari, MD | Abstract Presenter
12:15 PM
- 12:30 PM
Convention Center - General Session, Hall A
Early and week 52 biomarker (MRI-PDFF, ALT, MRE and PRO-C3) responses to resmetirom predict improvements in MASH and liver fibrosis
Rohit Loomba, MD, MHSc, FAASLD | Abstract Presenter
